🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Robert N. Schuck

United States Food and Drug Administration

ORCID: 0000-0002-5855-1361

Also affiliated with Center for Drug Evaluation and Research

Biochemistry, Genetics and Molecular BiologyMathematicsMedicinePharmacology, Toxicology and PharmaceuticsEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement”.

FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2036
N/A
1.6DataRank · unranked
60 citations

Leigh Marcus, M. Naomi Horiba, Martha Donoghue, Somak Chatterjee, Pallavi S. Mishra‐Kalyani +12 more

Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity

UNC Libraries(2020)10.17615/bkqs-7h74
N/A
0DataRank · unranked
1 citations

Fred B. Lih, Matthew L. Edin, Robert N. Schuck, Laura M. DeGraff, Kimberly C. Vendrov +8 more

The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease

UNC Libraries(2020)10.17615/0t4h-9v27
N/A
0DataRank · unranked
0 citations

Tricia M. Miller, Samuel M. Poloyac, Liza Makowski, Darryl C. Zeldin, Kenneth B. Tomer +11 more

Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease

UNC Libraries(2020)10.17615/h34m-4n70
N/A
0DataRank · unranked
0 citations

Robert N. Schuck, Samuel M. Poloyac, Katherine N. Theken, Craig R. Lee, Almasa Bass +9 more

Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients

UNC Libraries(2020)10.17615/fjvx-p429
N/A
0DataRank · unranked
0 citations

Kyle K. Ellis, Fred B. Lih, Almasa Bass, Katherine N. Theken, Craig R. Lee +11 more

Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice

UNC Libraries(2020)10.17615/f8bx-6k60
N/A
0DataRank · unranked
0 citations

Robert N. Schuck, Kimberly Molnar, Laura M. DeGraff, Darryl C. Zeldin, Fred B. Lih +6 more

Creating a Roadmap to Quantitative Systems Pharmacology–Informed Rare Disease Drug Development: A Workshop Report

Clinical Pharmacology & Therapeutics(2023)10.1002/cpt.3096
N/A
0DataRank · unranked
11 citations

Audra L. Stinchcomb, Jie Wang, Justin Earp, Sydney Stern, Robert N. Schuck +1 more

Clinical pharmacology considerations for first‐in‐human clinical trials for enzyme replacement therapy

Journal of Inherited Metabolic Disease(2024)10.1002/jimd.12746
N/A
0DataRank · unranked
4 citations

Jie Wang, Ruo‐Jing Li, Yuen Yi Hon, Shawna L. Weis, Yow‐Ming Wang +3 more

Assessment of Dosing Strategies for Pediatric Drug Products

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3250
N/A
0DataRank · unranked
6 citations

Francis G. Green, Nayeem Hossain, Gilbert J. Burckart, Michael Pacanowski, Robert N. Schuck +1 more

Leveraging in Vitro Models for Clinically Relevant Rare CYP2D6 Variants in Pharmacogenomics

Drug Metabolism and Disposition(2024)10.1124/dmd.123.001512
N/A
0DataRank · unranked
1 citations

Paula L. Hyland, Michael Pacanowski, Robert N. Schuck, Sydney Stern

Trends in clinical studies evaluating neurofilament light chain as a biomarker

Biomarkers in Medicine(2025)10.1080/17520363.2025.2562546
N/A
0DataRank · unranked
2 citations

Kristin M. Miner, Sreedharan Sabarinath, Shawna L. Weis, Robert N. Schuck, Michael Pacanowski +1 more

A Systematic Assessment of US Food and Drug Administration Dosing Recommendations For Drug Development Programs Amenable to Response‐Guided Titration

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2068
N/A
0DataRank · unranked
2 citations

Kimberly Maxfield, Daphne Guinn, Rajanikanth Madabushi, Issam Zineh, Robert N. Schuck +1 more

The Evaluation of Interactions Between Multiple Intrinsic and Extrinsic Factors Reported in Labeling for FDA‐Approved Drugs

The Journal of Clinical Pharmacology(2025)10.1002/jcph.70064
N/A
0DataRank · unranked
0 citations

Sydney Stern, Elyes Dahmane, Anuradha Ramamoorthy, Michael Pacanowski, Robert N. Schuck +1 more